- Home
- BBIO vs GNRC Comparison
BBIO vs GNRC Comparison
Compare BBIO & GNRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BBIO
- GNRC
- Stock Information
- Founded
- BBIO 2015
- GNRC 1959
- Country
- BBIO United States
- GNRC United States
- Employees
- BBIO N/A
- GNRC N/A
- Industry
- BBIO Biotechnology: Pharmaceutical Preparations
- GNRC Metal Fabrications
- Sector
- BBIO Health Care
- GNRC Consumer Discretionary
- Exchange
- BBIO Nasdaq
- GNRC Nasdaq
- Market Cap
- BBIO 8.8B
- GNRC 7.5B
- IPO Year
- BBIO 2019
- GNRC 2010
- Fundamental
- Price
- BBIO $47.27
- GNRC $194.88
- Analyst Decision
- BBIO Strong Buy
- GNRC Strong Buy
- Analyst Count
- BBIO 16
- GNRC 18
- Target Price
- BBIO $61.50
- GNRC $173.72
- AVG Volume (30 Days)
- BBIO 2.2M
- GNRC 1.2M
- Earning Date
- BBIO 08-05-2025
- GNRC 07-30-2025
- Dividend Yield
- BBIO N/A
- GNRC N/A
- EPS Growth
- BBIO N/A
- GNRC 54.62
- EPS
- BBIO N/A
- GNRC 6.03
- Revenue
- BBIO $127,415,000.00
- GNRC $4,411,654,000.00
- Revenue This Year
- BBIO $106.33
- GNRC $5.36
- Revenue Next Year
- BBIO $54.30
- GNRC $6.58
- P/E Ratio
- BBIO N/A
- GNRC $32.27
- Revenue Growth
- BBIO N/A
- GNRC 9.69
- 52 Week Low
- BBIO $21.72
- GNRC $99.50
- 52 Week High
- BBIO $48.68
- GNRC $197.18
- Technical
- Relative Strength Index (RSI)
- BBIO 64.57
- GNRC 83.74
- Support Level
- BBIO $45.11
- GNRC $150.67
- Resistance Level
- BBIO $47.11
- GNRC $157.33
- Average True Range (ATR)
- BBIO 1.40
- GNRC 6.41
- MACD
- BBIO -0.26
- GNRC 3.07
- Stochastic Oscillator
- BBIO 60.53
- GNRC 95.62
About BBIO BridgeBio Pharma Inc.
BridgeBio Pharma is a biotechnology company focused on discovering, developing, testing, and delivering transformative treatments for patients with genetic diseases. The company has four programs in its late-stage pipeline focusing on Mendelian disorders, oncology, and gene therapy. One of its key programs, Attruby (acoramidis) , is an orally administered small molecule designed to stabilize tetrameric transthyretin for the treatment of transthyretin amyloid cardiomyopathy.
About GNRC Generac Holdlings Inc.
Generac designs and manufactures power generation equipment serving residential, commercial, and industrial markets. It offers standby generators, portable generators, lighting, outdoor power equipment, and a suite of clean energy products. Sales generated in the United States account for the majority of total sales.